These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 6690032

  • 1. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A, Fuks Z, Gatt S, Glaubiger D.
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
    Ramu A, Shan TC, Glaubiger D.
    Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
    [Abstract] [Full Text] [Related]

  • 3. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
    Ramu A, Glaubiger D, Fuks Z.
    Cancer Res; 1984 Oct; 44(10):4392-5. PubMed ID: 6467200
    [Abstract] [Full Text] [Related]

  • 4. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD, Steinkampf RW, Havlick MJ, Jackson RC.
    Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
    Ganapathi R, Grabowski D, Rouse W, Riegler F.
    Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D.
    Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
    [Abstract] [Full Text] [Related]

  • 9. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D, Wilberding C.
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
    Kessel D, Wilberding C.
    Cancer Treat Rep; 1985 Jun; 69(6):673-6. PubMed ID: 4016770
    [Abstract] [Full Text] [Related]

  • 12. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M, Kobayashi H, Sakurai Y, Johnson RK.
    Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [Abstract] [Full Text] [Related]

  • 13. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [Abstract] [Full Text] [Related]

  • 14. Exploring multidrug resistance using rhodamine 123.
    Kessel D.
    Cancer Commun; 1989 Oct; 1(3):145-9. PubMed ID: 2639727
    [Abstract] [Full Text] [Related]

  • 15. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK, Chitnis MP, Embrey WM, Gregory EB.
    Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
    [Abstract] [Full Text] [Related]

  • 16. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R, Reiter W, Krishan A.
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [Abstract] [Full Text] [Related]

  • 17. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.
    Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875
    [Abstract] [Full Text] [Related]

  • 18. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
    Yanovich S, Preston L.
    Cancer Res; 1984 May 01; 44(5):1743-7. PubMed ID: 6713377
    [Abstract] [Full Text] [Related]

  • 19. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
    Ramu A, Glaubiger D, Weintraub H.
    Cancer Treat Rep; 1984 Apr 01; 68(4):637-41. PubMed ID: 6713419
    [Abstract] [Full Text] [Related]

  • 20. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E, Menconi E, Barzi AM.
    Boll Soc Ital Biol Sper; 1984 Jul 31; 60(7):1369-75. PubMed ID: 6477749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.